Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT
Avalo Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 192K | 249K | n/a | n/a | 571K | 236K | 643K | 475K | 896K | 14.95M | 1.03M | 1.17M | 219K | 1.35M | 3.35M | 473K |
Cost of Revenue | 134K | n/a | 87K | -714K | 343K | -80K | -221K | 247K | 708K | 551K | 620K | 528K | 1.57M | 720K | 424K | 908K | 83K | 77K |
Gross Profit | -134K | n/a | 105K | 963K | -343K | 80K | 792K | -11K | -65K | -76K | 276K | 14.42M | -534K | 453K | -205K | 442K | 3.27M | 396K |
Operating Income | -19.32M | -14.67M | -13.31M | -12.86M | -9.57M | -32.77M | -3.75M | -3.75M | -7.15M | -8.79M | -8.86M | 3.2M | -11.83M | -20.85M | -20.4M | -16.46M | -17.13M | -30.58M |
Interest Income | 1.1M | 1.15M | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K |
Pretax Income | -20.75M | -13.14M | -35.23M | 23.02M | 98.47M | -121.28M | -8.18M | -5.22M | -8.19M | -9.95M | -9.8M | 3.2M | -12.98M | -22.04M | -19.15M | -17.46M | -17.37M | -30.56M |
Net Income | -20.77M | -13.15M | -35.34M | 23.04M | 98.46M | -121.29M | -8.17M | -5.23M | -8.19M | -9.96M | -9.81M | 3.19M | -12.99M | -22.05M | -19.2M | -17.39M | -17.11M | -30.68M |
Selling & General & Admin | 5.11M | 5.55M | 5.23M | 4.29M | 4.53M | 3.19M | 2.68M | 2.49M | 2.43M | 2.71M | 2.96M | 3.28M | 2.78M | 11.68M | 5.98M | 5.93M | 7.4M | 5.35M |
Research & Development | 14.07M | 9.12M | 8.18M | 9.54M | 4.7M | 29.65M | 1.87M | 1.25M | 4.66M | 6.01M | 6.17M | 7.04M | 8.51M | 9.58M | 11.51M | 10.55M | 12.57M | 25.21M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17K | n/a | -26K | n/a | n/a | n/a | 38K | 267K | -15K | -5K | 424K |
Operating Expenses | 19.18M | 14.67M | 13.42M | 13.82M | 9.23M | 32.85M | 4.54M | 3.74M | 7.08M | 8.72M | 9.13M | 10.33M | 11.29M | 21.31M | 17.76M | 16.91M | 20.4M | 30.98M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.55M | 996K | 949K | 949K | 898K | 1.15M | 1.17M | 1.18M | 985K | 239K | n/a |
Selling & Marketing Expenses | n/a | 12K | 789K | n/a | 21K | 7K | 7K | n/a | 7K | 13K | 12K | n/a | 14K | 1.93M | 867K | 738K | 786K | 435K |
Cost & Expenses | 19.32M | 14.67M | 13.5M | 13.11M | 9.57M | 32.77M | 4.32M | 3.99M | 7.79M | 9.27M | 9.75M | 10.85M | 12.86M | 22.03M | 18.18M | 17.81M | 20.48M | 31.05M |
Income Tax Expense | 16K | 8K | 114K | -14K | 7K | 7K | -9K | 8K | 7K | 8K | 8K | 5K | 5K | 9K | -16K | 8K | -199K | 11K |
Shares Outstanding (Basic) | 10.83M | 10.51M | 10.47M | 8.13M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.84K | 39.25K | 39.22K | 39.17K | 39.16K | 39.63K | 34.89K | 37.71K | 32.94K |
Shares Outstanding (Diluted) | 10.83M | 10.51M | 10.47M | 10.78M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.84K | 39.25K | 39.22K | 39.17K | 39.16K | 39.63K | 34.89K | 37.71K | 32.94K |
EPS (Basic) | -1.92 | -1.25 | 13.89 | 2.83 | 95.21 | -141.14 | -10.19 | -26.83 | -140.73 | -203.81 | -249.99 | 81.38 | -331.55 | -563.03 | -484.39 | -498.52 | -453.56 | -931.42 |
EPS (Diluted) | -1.92 | -1.25 | 10.47 | 2.14 | 12.87 | -141.14 | -10.19 | -26.83 | -140.73 | -203.81 | -249.99 | 81.38 | -331.55 | -563.03 | -484.39 | -498.52 | -453.56 | -931.42 |
EBITDA | -20.61M | -14.53M | -13.24M | -12.83M | -9.54M | -32.73M | -8.21M | -3.71M | -7.11M | -8.96M | -8.82M | 4.13M | -11.8M | -20.81M | -17.67M | -16.02M | -16.68M | -30.13M |
EBIT | -20.75M | -14.67M | -13.31M | -12.86M | -9.57M | -32.77M | -8.26M | -3.75M | -7.15M | -9M | -8.86M | 4.09M | -11.83M | -20.87M | -17.96M | -16.48M | -17.13M | -30.58M |
Depreciation & Amortization | 134K | 135K | 68K | 34K | 33K | 34K | 43K | 41K | 41K | 33K | 35K | 34K | 30K | 67K | 295K | 455K | 456K | 451K |